Clinical-epidemiological characteristics and outcome of patients with catheter-related bloodstream infections in Europe (ESGNI-006 Study).

This study analysed 89 episodes of catheter-related bloodstream infection (CR-BSI) occurring during one week in 107 hospitals from 21 European countries (1.02 episodes/1,000 admissions). Patients from European Union (EU) countries had a higher incidence of CR-BSI than patients from non-EU countries (1.55 vs. 0.33/1,000 admissions). Most (67%) catheters were non-tunneled central venous catheters, were in the jugular vein (44%), had been implanted for > 7 days (70%), were made of polyurethane (61%) and were multi-lumen (67%). In 36% of cases, catheters were implanted by physicians other than anaesthetists or surgeons, and 50% were inserted by junior staff.

[1]  R. D. McCormick,et al.  Guidelines for the Prevention of Intravascular Catheter–Related Infections , 2002, Infection Control & Hospital Epidemiology.

[2]  D. Goldmann,et al.  A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. , 2001, Pediatrics.

[3]  L. Mermel,et al.  Guidelines for the Management of Intravascular Catheter-Related Infections , 2001, Infection Control & Hospital Epidemiology.

[4]  J. Timsit.  Scheduled Replacement of Central Venous Catheters Is Not Necessary , 2000, Infection Control & Hospital Epidemiology.

[5]  P. Domingo,et al.  Morbidity associated with long-term use of totally implantable ports in patients with AIDS. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  W. Hop,et al.  Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  R A Weinstein,et al.  Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. , 1998, Archives of internal medicine.

[8]  D. Cook,et al.  Central venous catheter replacement strategies: a systematic review of the literature. , 1997, Critical care medicine.

[9]  A. Widmer,et al.  Intravascular catheter-associated infections. , 1997, Schweizerische medizinische Wochenschrift.

[10]  C. Alvarado,et al.  Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters , 1991, The Lancet.

[11]  H. Richet,et al.  Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients , 1990, Journal of clinical microbiology.

[12]  R. Siegel,et al.  Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. , 1990, Critical care medicine.

[13]  S. Vas,et al.  CHANGING SUBCLAVIAN HAEMODIALYSIS CANNULAS TO REDUCE INFECTION , 1981, The Lancet.

[14]  H P Loveday,et al.  The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England). , 2001, The Journal of hospital infection.

[15]  M. Żywicki.  Monitoring hospital-acquired infections to promote patient safety--United States, 1990-1999. , 2000, MMWR. Morbidity and mortality weekly report.

[16]  C. Mayhall.  Diagnosis and management of infections of implantable devices used for prolonged venous access. , 1992, Current clinical topics in infectious diseases.